Headache News

Pregabalin and topiramate significantly reduced the frequency and intensity of migraines in children and adolescents, especially when combined with vitamin supplements, according to a meta-analysis published in JAMA Network Open.

Migraine is a complex neurological disease that disproportionately affects women during their most productive years.

ORLANDO, Fla. — Although children often suffer from headache, there are few controlled trials that include this unique patient population, leaving clinicians to rely on their experience rather than data, according to a presenter.

Around one-third of former professional football players perceived themselves as having chronic traumatic encephalopathy, according to results from a cross-sectional study published in JAMA Neurology.

ORLANDO, Fla. — To properly address headache care gaps in rural areas, clinicians must focus on boosting access, improving health literacy and formulating simple but informative plans for medication usage, according to a speaker.

The FDA has accepted the resubmission of a new drug application for a novel, oral therapeutic intended to treat individuals with acute migraine, according to the manufacturer.

A novel digital therapeutic for migraine prevention met its primary endpoint of reducing the number of monthly migraine days, according to results from a phase 3 clinical trial.

In patients with difficult-to-treat migraine, IV infusion of a novel monoclonal antibody provided superior migraine frequency relief compared with placebo in as early as 4 weeks, data show.

Prodromal treatment with 100 mg ubrogepant was associated with greater functionality, fewer activity limitations and a high degree of satisfaction at 24 hours in patients with migraine, according to research published in Neurology.